Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
|Articles|December 1, 2010
AAPS 2010 Science Award Winners: Shardool Jain
Advertisement
A Joint Presentation of Pharmaceutical Technology and
Interviews with the 2010 AAPS Science Award Winners
Shardool Jain
PhD Candidate, Northeastern University
Award: AAPS Graduate Symposium Award in Biotechnology for research in "Tuftsin-Modified Alginate Based Nanoparticles for Local and Systemic Anti-Inflammatory Gene Therapy"
View Full Research Presentation
Winners
Listen to the Interviews
AAPS President
Dr. Danny Shen, president of AAPS, discusses the level of scientific innovation and industry trends.
Listen>>
Advertisement
Related to this article
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
Advertisement
Advertisement